President Donald Trump's latest tariff deadline, business leaders, market participants and economists were still guessing ...

European equities have outperformed U.S. stocks by the widest margin since 2000 amid optimism about a stabilizing economy, and the prospect of increased fiscal stimulus and an end to war in Ukraine.

Drugmaker AbbVie has agreed to license a weight-loss drug currently in development from Gubra for up to about $2.2 billion, marking its entry into the obesity treatment market.

Honda Motor plans to produce its next Civic hybrid in Indiana rather than Mexico to avoid the impact of upcoming tariffs, according to a Reuters report.

Palantir shares surged Monday as Wedbush analysts called it one their "top names" to own in 2025, expecting it to benefit from a "tidal wave of spending on AI." ...

The Institute of Supply Management's manufacturing PMI survey for February showed slower-than-expected growth, as tariff ...

Anthropic said it raised $3.5 billion in its latest funding round, giving the Amazon- and Google-backed AI startup a $61.5 billion post-money valuation.

Target is set to report fourth-quarter earnings on Tuesday morning, with analysts largely bullish on the retailer's stock.

Federal student loan borrowers facing rising tuition costs and unexpected lawsuits on repayment plans have turned to their communities for help paying college costs.

U.S. stock futures point higher to start week, crypto-related stocks soar after President Trump gives details of U.S.

Tesla was named the "Top Pick" for U.S. auto firms by Morgan Stanley, which pointed to the EV maker's moves into AI and ...

Stock futures are rising Monday as the market looks to kick off the month on a high note after losing ground in February.